A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients
NCT ID: NCT04674150
Last Updated: 2021-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
20 participants
INTERVENTIONAL
2021-01-13
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility/Acceptability of Attentional-Control Training in Survivors
NCT05528939
Resources for Optimizing Outcomes in Toddlers on the Spectrum
NCT07086781
Sensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for ADHD
NCT05222321
A Randomized Control Trial of a Responsive Parenting Intervention to Support Healthy Brain Development and Self-regulation in Toddlers Born Preterm
NCT04856501
Therapeutic Gaming for the Treatment of Attention Deficit Hyperactivity Disorder
NCT05067322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-AR Group
Patients allocated to the control group will be able to interact with the iPad and visualize objects and decals in the walls but not able to initiate the AR technology. In other terms, patients in this group will be provided with the same iPad to the AR group patients with the only exception that the AR technology will be off and will only see objects through the device camera in normal reality.
ARISE without AR
An augmented reality game for mobile devices with AR experiences disabled as an control
AR Group
Patients randomized to the AR group will be able to use the iPad and SpellBound app to initiate the AR experiences in the game.
ARISE with AR
An augmented reality game for mobile devices with AR experiences enabled
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ARISE with AR
An augmented reality game for mobile devices with AR experiences enabled
ARISE without AR
An augmented reality game for mobile devices with AR experiences disabled as an control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English speaking parents/legal guardians and patients
3. Undergoing major surgery for cancer requiring postoperative hospitalization defined as ≥2 hours of duration of surgery and requiring postoperative hospital admission of at least one night
4. Expected to be prescribed postoperative inpatient opioids
5. Have never taken opioids or have had no daily opioid use within the last 30 days
6. Sufficient cognitive capacity to comprehend and interact with the game. This is defined as ability to utilize mobile technology (use iPad with or without assistance) and activate and respond to AR experiences within the app as determined by the clinician.
7. Both child and a legal guardian are willing and able to provide informed consent.
Exclusion Criteria
2. Inability to demonstrate an understanding of the game from English instructions
3. Have previous played the ARISETM digital scavenger hunt game
4. Any additional concerns based on the study physicians' assessments
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
M.D. Anderson Cancer Center
OTHER
Baylor College of Medicine
OTHER
ALTality, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina York
Role: PRINCIPAL_INVESTIGATOR
ALTality, Inc.
Juan Cata, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas at Houston MD Anderson Cancer Center
Jamie Sinton, MD
Role: PRINCIPAL_INVESTIGATOR
The Texas Children's Hospital
Jae Eun Choi
Role: STUDY_DIRECTOR
ALTality, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M.D. Anderson Cancer Center
Houston, Texas, United States
Texas Children's Hospital
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARISE GAMING (Phase I)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.